Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
about
Systemic therapy of Cushing's syndromeThe Treatment of Cushing's Disease.Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaNeuropsychiatric disorders in Cushing's syndromeCushing's syndrome: epidemiology and developments in disease management.Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineResidual manifestations of hypercortisolemia following surgical treatment in a patient with Cushing syndrome.Cushing's syndrome: update on signs, symptoms and biochemical screening.Current best practice in the management of patients after pituitary surgery.Silent pulmonary thromboembolism in neurosurgery patients: Report of 2 cases and literature review.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Clinical and biochemical manifestations of Cushing's.Overview of venous thrombosis in inflammatory bowel disease.5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications.Treatment of giant-cell arteritis, a literature review.Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.Coagulation Profile Dynamics in Pediatric Patients with Cushing Syndrome: A Prospective, Observational Comparative Study.Acute mesenteric ischemia and hepatic infarction after treatment of ectopic Cushing's syndrome.Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.Severe Cushing's syndrome and bilateral pulmonary nodules: beyond ectopic ACTH.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis.Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?Recent Updates on the Diagnosis and Management of Cushing's Syndrome.
P2860
Q22000607-B9FD768A-E69E-4BC9-8B98-5E6F6ACCE1A8Q27010590-3AC7C801-6446-44B9-A08B-50B5B25BFA5CQ34431162-7372DD10-2D3F-4C4B-9A65-6C9E6F979A35Q35487292-DFB03FD9-8B1D-400F-A224-FBF01AD18C39Q35531889-3C22814D-5ADA-4361-9DA8-7A0734B2B9EEQ35916555-B9CB0D53-F0B2-41A0-82D1-FA753BED72D4Q36000914-B10E32F3-64E8-4B72-BDC7-26E8FD7667B0Q36005863-72116B39-564C-4AF0-B5B2-7318E818585BQ37718163-588C6C7B-7119-475E-ACF0-8C0D777A1F5CQ37726758-80D7E3E2-F996-40A4-819C-F51EF1354A39Q38261764-10641F94-4039-404A-A303-FE5FA7BB9C84Q38311631-BFB51C94-E913-4455-A857-984987DF25E7Q38315631-64B07F32-1F9F-41D6-847A-59B99EA3D594Q38667419-8A6D66F6-FBAD-4C04-A805-6AB8C15871D9Q39029638-EE15F577-2667-4A5E-9DFB-301D61F8FA0AQ39074559-3EB489F4-C88F-4D81-B420-36F019291FFDQ40795123-F116AD1C-0876-4386-AC39-64273E924E88Q41651316-633CD85E-4723-4993-86D1-9D1AC42256F0Q42289866-A97FA897-C944-4674-B14C-BE537A5481A4Q45856680-C4FBFDFB-859B-42C3-82F1-FBB0CFDF90BBQ46445397-ABADA5BA-EE7E-4156-8BCE-5ED518017F7BQ50003119-C74EFEB7-28DE-4386-8136-2A8CE9FD6717Q53439990-DFC01865-ABA6-4AB8-A60E-07D289ADD013Q55387370-5639282B-068E-4916-AD7D-8D3BC5BC682A
P2860
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
@en
type
label
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
@en
prefLabel
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
@en
P2093
P2860
P356
P1476
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
@en
P2093
F W G Leebeek
L J Hofland
R A Feelders
R van der Pas
W W de Herder
P2860
P304
P356
10.1111/CEN.12094
P577
2013-04-01T00:00:00Z